SSRI-induced mania
SSRI-induced mania is a mood that goes up after an antidepressant is started or the dose changed: less need for sleep, racing thoughts, irritability, risky decisions. It is a change from your usual self that holds for days, not hours. Milder forms are called hypomania. In US depression trials it was reported in fewer than 1 in 100 people, but people with bipolar disorder were mostly left out of those trials, and the risk is higher for them and for people with a family history of it. If you notice these changes, contact your prescriber promptly rather than waiting for your next appointment.
Also called: Hypomania on antidepressants, Antidepressant-induced mania, Manic switch.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
What does mania or hypomania on an SSRI look like?
It is a mood that goes up instead of down, and it starts close to a medication change. NIMH lists what a manic episode is made of, and says that during an episode the symptoms are there every day for most of the day.
- Less need for sleep: A decreased need for sleep, and feeling jumpy or wired rather than tired on very little of it.
- Racing thoughts: Thoughts running fast, talking fast about a lot of different things, and feeling able to do many things at once without getting tired.
- Mood up or irritable: Feeling very up, high or elated, or extremely irritable and touchy, and feeling unusually important, talented or powerful.
- Decisions that are hard to undo: Being more active than usual, with an excessive appetite for food, drink, sex or other pleasurable activities, and difficulty keeping up work, social life or relationships.
Hypomania is the same shape, smaller. NIMH says hypomanic episodes are like manic episodes but less severe and do not interfere as much with daily life, that they can make someone feel very good and productive and not feel anything is wrong, while family and friends notice the mood and activity changes as unusual. US labels name the same thing in their own list of symptoms reported on antidepressants, where impulsivity, akathisia, hypomania and mania sit next to anxiety, agitation and insomnia.
Can SSRIs cause mania in non-bipolar patients?
Yes, and in depression trials it was uncommon. In placebo-controlled trials of Lexapro in major depressive disorder, activation of mania or hypomania was reported in one of 715 patients on the drug, which is 0.1%, and in none of the 592 on placebo. The Prozac label reports mania or hypomania in 0.1% of people on the drug and 0.1% on placebo in depression trials, and in 0.8% against none in OCD trials. On Zoloft the figure was 0.4%, in trials that generally excluded people with bipolar disorder.
Outside trials the numbers run higher. A 2013 review gathered 51 reports of people diagnosed with major depressive disorder and treated with an antidepressant, 95,786 people in all, and found a switch into mania, hypomania or a mixed state in 8.18% over about 2.4 years. Across ten controlled trials in the same review the risk was 2.6 times greater on an antidepressant than without one. A 1997 study of 203 consecutive outpatients in one private practice shows how much the diagnosis matters: a switch into hypomania or mania over 3 to 6 months in 5.8% of the unipolar patients and 17.3% of those with bipolar II, a threefold difference.
Young people are a separate case, and the US label has a figure of its own. Across three pediatric placebo-controlled trials of fluoxetine, mania or hypomania was the most common reason people stopped taking it, 1.8% of the 228 on fluoxetine against none of the 190 on placebo. The 2013 review of juvenile trials counted more, mania or hypomania in 8.19% on an antidepressant against 0.17% without one, but that figure covers several different antidepressants and two different diagnoses: 10.4% in the 17 depression trials and 1.98% in the 25 anxiety trials.
How to calm down hypomania?
Not on your own, and not by changing the dose yourself. Hypomania that started with a medication is a same-day call to your prescriber, because what happens next, whether the dose is held, lowered or stopped, is their decision and it turns on your history. MedlinePlus lists frenzied abnormal excitement among the things to call your doctor about right away on fluoxetine.
While you wait to speak to them, ask someone close to you to keep an eye on decisions that are hard to undo, such as spending, driving or quitting a job, since NIMH notes that family and friends often see the change before the person does. MedlinePlus asks for the same thing in its own words, that your family or caregiver know which symptoms may be serious so they can call the doctor if you are unable to seek treatment on your own. If you have thoughts of harming yourself, call or text 988 in the US, or your local emergency number. If you or someone else is in immediate danger, call 911, or ask someone with you to call.
How long does antidepressant-induced mania last?
The length that has been measured belongs to mood episodes in bipolar disorder, not to a lift that follows a dose change. NIMH says symptoms of a mood episode last a week or two, sometimes longer, and that during an episode they are there every day for most of the day. US labels put no average on mania that starts on an antidepressant.
In practice the length depends on what is changed and when. That is the reason to date the start: when the mood lifted, what dose you were on, and what changed in the days before. Your prescriber reads that differently from a general account of a strange couple of weeks.
Does drug-induced mania mean you are bipolar?
Not by itself, and it is not a question to settle alone either. US labels ask prescribers to screen for a personal and family history of bipolar disorder, mania or hypomania before an antidepressant starts, because a depressive episode can be the first appearance of bipolar disorder. An episode that shows up after a medication change is a reason to go back over that history together.
A switch is more common than a later diagnosis. In the same 2013 review, a new diagnosis of bipolar disorder came in 3.29% of 56,754 people over 5.38 years, which year for year is about 5.6 times lower than the rate of switching. The authors say how much of the switching comes from unrecognized bipolar disorder and how much from the medication itself is still uncertain.
Mania and activation also read differently on paper. A 2025 systematic review of SSRI activation and manic switch in people aged 6 to 18 found reports of activation naming aggression and hostility, anxiety and panic, and suicide and self-harm more often, while reports of mania named changes in thinking and in mood and emotions. Where bipolar disorder is already diagnosed, mania during antidepressant treatment is common: a 2018 meta-analysis of 10,098 people with bipolar depression found it in 11.8% across 20 randomized trials and 30.9% across 15 retrospective studies, with the lowest rates where lithium was taken alongside. The juvenile review ends on a related note, that excessive activation calls for monitoring for the possible risk of future bipolar disorder.
What to do
Write down the date the mood changed, the dose you were on, any dose change in the two weeks before, your hours of sleep, and the decisions that were out of character. Ask someone close to you what they noticed and when. Call your prescriber the same day rather than waiting for the next appointment, and ask whether a bipolar screen belongs in the conversation. If you have thoughts of harming yourself, call or text 988 in the US, or your local emergency number, and if you or someone near you is in immediate danger, call 911.
Find mental health help in the US
How withClaro helps
- Log mood and sleep each day, next to your dose
- See which dose change came before the swing
- Share a PDF report with your prescriber
Get the withClaro app on the App Store
Related terms
Sources
- U.S. Food and Drug Administration. Lexapro (escitalopram) tablets and oral solution: prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Prozac (fluoxetine): prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Zoloft (sertraline) tablets and oral solution: prescribing information. FDA / DailyMed, 2025.
- National Institute of Mental Health. Bipolar disorder. NIMH (nimh.nih.gov), 2025.
- U.S. National Library of Medicine. Fluoxetine. MedlinePlus, 2025.
- Baldessarini RJ, Faedda GL, Offidani E, Vazquez GH, Marangoni C, Serra G, Tondo L. Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. Journal of Affective Disorders, 2013.
- Benazzi F. Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice. Journal of Affective Disorders, 1997.
- Offidani E, Fava GA, Tomba E, Baldessarini RJ. Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review. Psychotherapy and Psychosomatics, 2013.
- Fornaro M, Anastasia A, Novello S, Fusco A, Solmi M, Monaco F, Veronese N, De Berardis D, de Bartolomeis A. Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis. Bipolar Disorders, 2018.
- Dadfar A, Ramklint M, von Wallenberg Pachaly S. A systematic review of selective serotonin reuptake inhibitor (SSRI)-induced activation and manic/hypomanic switch in children and adolescents. Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, 2025.
All glossary terms